These approaches and the possible combinationof hemin or one of its derivatives with other breast cancer therapeuticstoward a more effective treatment approach for TNBC are currentlybeing investigated, by comparing their effects to those of aminoguanidineon iNOS-transfected TNBC cells. Here, NOS2 is linked to breast carcinoma.